Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.
Genetic and acquired abnormalities in complement factor H (CFH) have been associated with two different human renal diseases: haemolytic uraemic syndrome and membrano proliferative glomerulonephritis. The new genetic and pathogenetic findings in these diseases and their clinical implications for the management and cure of patients are reviewed in this paper.
Noris
M
M
Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Villa Camozzi - Ranica (BG), Italy. noris@marionegri.it
Remuzzi
G
G
D017242:Complement Factor H / Q000235:genetics; D015432:Glomerulonephritis, Membranoproliferative / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D006463:Hemolytic-Uremic Syndrome / Q000235:genetics* / Q000276:immunology / Q000628:therapy; D006801:Humans
C493495:CFH protein, human; D017242:Complement Factor H